HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Study Identifying "Secret" Chemicals In Popular Fragrances Spurs Legislation

This article was originally published in The Rose Sheet

Executive Summary

A report from consumer advocacy groups on the risks of "secret" fragrance chemicals has lawmakers polishing legislation to overhaul current cosmetics and fragrance labeling laws

You may also be interested in...



Feinstein Bill To Mandate Fragrance Ingredient Contacts, Not Disclosure

Cosmetics legislation poised for introduction in the Senate is likely to uphold the trade-secret status of fragrance compositions, promoting “a direct communication line” between FDA and fragrance houses rather than requiring full disclosure of fragrance ingredients, according to IFRA North America.

Women’s Voices Join In Fragrance Disclosure Debate, Citing Allergy Risks

NGO Women’s Voices for the Earth says the rising incidence of fragrance allergy worldwide points to a need for fragrance ingredient disclosure. In an online petition, the group is calling on IFRA to establish “an industry-wide policy” of full transparency so consumers can make informed choices about fragranced product use.

IFRA Videos Designed To Educate, Feel Out Public On Ingredient Disclosure

The International Fragrance Association steps up its PR with a pair of videos designed to educate consumers about perfumery and the importance of preserving trade secrets.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel